drugset / Trial / NCT00970528
Glucose Reduction by Early Acarbose Treatment in Basal Insulin
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of acarbose in comparison with voglibose in type 2 diabetic patients whose blood glucose levels were inadequately controlled with insulin glargine alone or in combination with metformin.
Timeline
- Start
- 2009-11
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 100 mg | — |
| Comparator | Voglibose | Small molecule | 0.3 mg | — |